Profil von eqs_en
Blog
EQS-News: Abivax Reports Positive ABTECT Maintenance Part 2 Results for Obefazimod, Demonstrating Meaningful Clinical Benefit in Refractory UC Patients and Strengthening the Phase 3 Maintenance Safety Database
EQS-News: Abivax Reports Positive ABTECT Maintenance Part 2 Results for Obefazimod, Demonstrating Meaningful Clinical Benefit in Refractory UC Patients and Strengthening the Phase 3 Maintenance Safety Database
EQS-News: Shelly Group SE: Annual General Meeting approves dividend of EUR 0.13 per share – shareholders approve all agenda items
EQS-News: Shelly Group SE: Annual General Meeting approves dividend of EUR 0.13 per share – shareholders approve all agenda items
EQS-Adhoc: H&R GmbH & Co. KGaA: Earnings performance significantly exceeding expectations in the second quarter of 2026 – potential target achievement already by mid-year
EQS-Adhoc: H&R GmbH & Co. KGaA: Earnings performance significantly exceeding expectations in the second quarter of 2026 – potential target achievement already by mid-year
Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc